| Literature DB >> 19894726 |
Mei Yang1, Chika Arai, Abu Bakar Md, Jun Lu, Jian-Feng Ge, Khanitha Pudhom, Kiyosei Takasu, Kazuki Kasai, Marcel Kaiser, Reto Brun, Vanessa Yardley, Isamu Itoh, Masataka Ihara.
Abstract
Anti-Leishmania in vitro and in vivo activities of various rhodacyanine derivatives have been examined. Among them, the fluorinatied variant SJL-01 (8) showed IC(50) of 0.011 microM against Leishmania donovani strain MHOM/ET/67/L82 (selective index of >15000) and 95-97% inhibition against L. donovani strain MHOM/ET/67/HU in female BALB/c mice by 1.3-12.5 mg/kg x 5 iv administrations. Negative results on chromosomal aberration test and in vitro micronucleus test suggest that compound 8 is a hopeful candidate for visceral leishmaniasis (VL).Entities:
Mesh：
Substances：
Year: 2010 PMID： 19894726 DOI： 10.1021/jm9013086
Source DB: PubMed Journal: J Med Chem ISSN： 0022-2623 Impact factor: 7.446